Cetrorelix Acetate

醋酸西曲瑞克

Report date: 2023/03/22 17:26:54
NME

Base Information

Drug NameCetrorelix Acetate
Drug Alias NamecetrorelixCetrorelix pamoatecetrorelixumCetrotide思则凯 +[12] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGonadotropin-releasing hormone receptor antagonists
TargetsGonadotropin-releasing hormone receptor
Therapy Area/IndicationsEndocrine System DiseasesInfertility, FemaleEndometriosis +[8] 
Global Approved IndicationsEndocrine System DiseasesInfertility, Female
Approved Indications in ChinaInfertility, Female
Original Approved Country/TerritoryEU
Original Approved Date1999/04/13
Country/TerritoryCzechiaBelgiumBulgaria +[23] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Serono
China Registration ClassN/A

Develop Information

Active CompaniesFerring BvBaxter Oncology GmbhMerck Serono
Inactive CompaniesCairo UniversityBenha UniversityWoman'S Health University Hospital, Egypt +[9] 
Active IndicationsEndocrine System DiseasesInfertility, Female
Inactive IndicationsEndometriosisOvarian Hyperstimulation SyndromeProstatic Hyperplasia +[6] 

Other Information

ATC CodeH01CC02
Related LinksWikipediaDrugBankKEGG